The aim of this longitudinal study was to assess the frequency of nonrevers
ible airflow obstruction (NRAO) among adults with moderate to severe asthma
, and to compare the decline of forced expiratory volume in one second (FEV
1) in asthmatics with reversible and nonreversible airflow obstruction.
Ninety-mo (31 males) life-long nonsmokers dth asthma participated in a 10-y
r follon-up study; mean age 37 yrs (range 18-64) and duration of asthma 16
yrs (range 2-60) at enrolment. Case history, including use of asthma medica
tion, was obtained, and pulmonary function, including diffusion capacity, w
as measured using standard techniques. At enrolment, all patients had typic
al symptoms and reversible airflow obstruction. (NRAO) was defined as FEV1
<80% predicted and change in Delta FEV1 after 5 mg salbutamol <9% pred.
A total of 21 (23%) patients (mean age at enrolment 32 yrs) fulfilled the c
riteria for NRAO at the time of follow-up; current therapy nas inhaled ster
oids (n=21, mean daily dose 1.5 mg), oral steroids (n=14), theophylline (n=
20), oral beta(2)-agonist (n=6) and inhaled Pt-agonist. The patients with N
RAO (n=21) had a steeper decline in FEV1 than the remaining patients (n=71,
reversible airflow obstruction (RAO)), mean+/-SD, 53+/-23 mL.yr(-1) and 36
+/-21 mL,yr(-1), respectively (p<0.003). Increasing degree of branchodilato
r reversibility (Delta FEV1 % pred) at enrolment (p=0.002) and long-term tr
eatment with oral corticosteroids (p=0.009) were associated with an increas
ed risk for the presence of NRAO at follon-up. The comparison of data for N
RAO and RAO patients (at follow-up) revealed no significant differences in
mean values for total diffusion capacity (rr,co), diffusion constant (KCO),
or total lung capacity.
The findings suggest that a subgroup of asthmatics may experience very stee
p rates of decline in forced expiratory volume in one second Leading to sev
ere nonreversible airflow obstruction, whereas no indication was found that
long-standing asthma may lead to the development of emphysema.